Why COVID-19 patients who could most benefit from Paxlovid still aren’t getting it
American Nurse
MARCH 13, 2024
The drug might have prevented up to 27,000 deaths in 2022 if it had been allocated based on which patients were at highest risk from covid. In fact, the drug is still free for those who are uninsured or enrolled in Medicare, Medicaid, or other federal health programs, including those for veterans. government 23.7
Let's personalize your content